Media Advisory - Innovative Medicines Canada to Publish Results of 2016 Access to Medicines Report

OTTAWA, May 20, 2016 /CNW/ - Innovative Medicines Canada will publish the results of their 2016 report on access to medicines in Canadian public drug plans, detailing the significant delays Canadians face in accessing medicines compared to international comparators at a press conference, with Executive Director, Communications Isabelle Robillard and Brett Skinner, Executive Director of Health and Economic Policy. Larry Taylor will also be present to explain the impact on patients suffering from diabetes.

Date:	Tuesday, May 24, 2016
Time:	10:00 am - 10:45 am
Location:	National Press Theatre
	150 Wellington Street Ottawa, Ontario K1A 0A8

About Innovative Medicines Canada

Innovative Medicines Canada is the national voice of Canada's innovative pharmaceutical industry. We advocate for policies that enable the discovery, development and commercialization of innovative medicines and vaccines that improve the lives of all Canadians. We support our members' commitment to being valued partners in the Canadian healthcare system.

SOURCE Innovative Medicines Canada

Heather Brennae, Media Relations, Telephone: [phone] ext. 527 , E-mail: [email protected]